New today“A double beat and still -11%: the market isn't punishing this quarter's ledger, it's punishing management for thinning out the full-year story with its own hands — pushing $100M+ of bioprocessing revenue into 2027 tells you the recovery needs another year. Institutional distribution on 7x volume doesn't clear in a day; before catching this knife, let it hit the floor — the real negotiating table is the $160.93 52-week low”
Score7/10Day -11.0% on 7x volumeQ2 results Beat on revenue & EPSFY core growth guide Cut 3-6% → 3-4%RSI(14) 37.9
Technicals — The -11% close at $179.01 sliced straight through the 50-day ($183.3), sits 12.4% under the 200-day ($204.3), and RSI 37.9 isn't even oversold yet. Distribution at 7.18x volume takes time to absorb; support waits at $170 and the $160.93 52-week low, while any bounce first faces the $183-195 gap-fill zone
Fundamentals — Q2 itself was clean: revenue $6.27B (+5.5%, a beat), adjusted EPS $1.94 (+8%), and full-year EPS guidance actually raised to $8.45-8.60. The damage is all top-line — full-year core growth cut to 3-4%, Q3 at just 2-3%, bioprocessing downgraded from high to mid single digits. Management insists bioprocessing orders grew mid-teens and demand is delayed, not destroyed
News — The 7/21 pre-market report triggered the gap: the ugliest line was $100M+ of bioprocessing revenue slipping to 2027 on customer project timing, with the stock down as much as 14.6% intraday. Post-earnings target revisions haven't printed yet — consensus still reflects pre-crash ~$235 and 88% Buy ratings, and the coming wave of cuts is itself a second source of pressure
Short-term · 2-4 weeks
NeutralSidelines
Guidance cut, 7x-volume distribution and an unlanded wave of target cuts — three pressures argue against catching the first knife. If $165-172 (above the 52-week low) holds on shrinking volume, the gap-fill toward $195 becomes playable with a stop under the low
Entry Scale in on stabilization at $165-172Stop $159Target $195
Long-term · months+
Neutral
Bioprocessing orders up mid-teens say demand is on the mend and the 61%-gross-margin compounder DNA is intact; but a recovery deferred to 2027 needs two or three quarters of proof, leaving the multiple catalyst-poor meanwhile
Bioprocessing recovery slipping again
A second leg down as post-earnings downgrades land
Soft healthcare capex bleeding into diagnostics
Community Voices
WSB · A rare medtech name on the trending list — retail sees -11% and yells 'dip,' but sell orders at 7x volume never lack confident knife-catchers on the other sideOriginal ↗
Institutional Views
华尔街共识 · 29 analysts average $240 (a pre-crash number) at a 1.22 Strong Buy — but post-earnings cuts haven't landed yet, so the headline +34% upside will shrink
0.00%07-18“An AI model cobbled together a 45nm chip in 48 hours with open-source tools and scared $15.8B off the EDA duopoly — never mind that 45nm is fifteen-year-old process tech and any real moat erosion is years out; the market shoots the multiple first and asks questions later. An RSI-29 bounce is allowed, but until Kimi K3's full technical report drops on 7/27, this is a battlefield, not a bottom”
Technicals — Tuesday's +2.8% to $389.07 was technical repair after five straight down days (pre-market RSI touched 22.9), just 6% above the $366 52-week low. Everything from $434 (SMA20) to $453 (SMA200) overhead is trapped supply and the intermediate structure is broken; below $366 there is no consolidation shelf
Fundamentals — The 5/27 report beat on both lines and raised full-year revenue guidance past $9.6B, but Design IP falling 6% (cumulative China export-control damage) exposed the soft rib. A 90x multiple's defense rests on the monopoly assumption that design complexity only ever rises — precisely the foundation Kimi K3 is attacking
News — The 7/17 rout: Kimi K3 reportedly took a chip from RTL to simulated tape-out in 48 hours on purely open-source EDA (Nangate library, 4mm² die, 100MHz) without touching Synopsys or Cadence software, vaporizing a combined $15.8B — BNP called it an overreaction and a buy the same day. Stack on Ansys antitrust noise and the halt of certain process-control software to Samsung, Hynix and others. K3's full weights and technical report land 7/27, the same day as Cadence earnings — the actual moment of proof or disproof
Short-term · 1-2 weeks
NeutralSidelines
RSI 29 within 6% of the 52-week low gives decent bounce odds, but 7/27 is binary: if the report shows a path to advanced nodes, $366 won't hold; if it's a toy-grade demo, the gap-fill to $434 follows naturally. No size before the event
Entry Reassess after the 7/27 K3 report; aggressive traders may probe $370-385 smallStop $364Target $434
Long-term · months+
Neutral
The EDA duopoly remains irreplaceable at advanced nodes near-term and the Ansys merger completes the simulation map; but 90x earnings meeting an 'AI democratizes design tools' narrative means the valuation ceiling has been genuinely lowered
The 7/27 K3 report proving the open-source flow scales
China IP revenue shrinking further under export controls
Ansys integration antitrust and execution risk
Community Voices
StockTwits · Bulls shout 'a 45nm toy proves nothing'; bears answer 'that's what you said about AI writing code two years ago' — the debate itself is the cost of carryOriginal ↗
Institutional Views
华尔街共识 · 26 analysts average $570, +46% upside, 1.31 in Strong Buy territory — sell-side models don't yet have an 'open-source EDA' variable
BNP Paribas · Called the 7/17 Kimi K3 selloff an overreaction and recommended buying the dipSource ↗
Benchmark · Initiated Buy at $570 on 7/16; Citi also maintains Buy with a raised $610 targetSource ↗
-9.27%07-07“The delivery number has been face-up on the table since 7/2 — tonight flips the hole cards: auto gross margin and a projected -$3.25B free cash flow, with the options market quoting its widest earnings straddle in a year at ±6%. Betting direction into the print isn't analysis, it's rolling dice; our rule is to let them land and read the pips before wagering”
Score7/10Earnings Tonight after close (7/22)Implied move ±6%Q2 deliveries 480,126 (best Q2 ever)Storage deploy 13.5 GWh (+50% QoQ)
Technicals — Tuesday's +2.5% close at $378.93 remains capped beneath all three averages — 20/50/200-day at $395/$409/$416 — with RSI soft at 43. An upside earnings break targets $395 then the $416 band; downside finds support at $360 and $347 (prior lows). The ±6% implied move maps to roughly $356-402
Fundamentals — At 346x earnings the market has never been pricing cars — it's pricing Robotaxi and Optimus. This quarter is about earnings quality: auto gross margin ex-credits expected at 18-20%, revenue ~$26.2B (+16%), $6.7B of capex flowing into Optimus, AI datacenters and Cybercab capacity, with free cash flow expected negative
News — Earnings land tonight after the close with the call at 5:30pm ET — sharing the stage with Alphabet as this week's AI-capex referendum. The recent backdrop isn't bad: unsupervised Robotaxi went live in Miami 7/5 (Phoenix, Orlando, Tampa and Vegas slated by year-end), European registrations ran +57.2% for Jan-May, and NHTSA closed its phantom-braking probe. Yet the stock still lost 5% on the week — the market won't pre-pay for hole cards
Short-term · 1-2 weeks post-earnings
NeutralSidelines
An earnings night with a ±6% straddle offers no disciplined entry; go long only on a post-print volume reclaim of $395, step aside below $360 — trade confirmation, not prediction
Entry Wait for post-print confirmationStop —Target —
Long-term · months+
Neutral
Storage and Robotaxi are real second and third acts, but 346x earnings has already discounted most of the coming decade; until core auto margins stabilize, the multiple rests on narrative alone
Auto gross margin below 18% triggering a double derating
Robotaxi city-expansion pace and regulatory uncertainty
Sustained negative FCF against heavy capex
Signal BacktestCumulative -9.27%price itself -10.90%0/1 closed trades won
07-07Long$419.77 → closed $380.8407-18-9.27%
Community Voices
WSB · Mentions fell 77→49 into the print — retail actually went quiet before earnings night; even the gamblers admit they can't read these oddsOriginal ↗
Institutional Views
华尔街共识 · 51 analysts average $407, +7.5% from here, at a Hold-leaning 1.77 — with a $25-600 range too wide to mean anything
Morgan Stanley · Target raised to $417, Equal Weight: constructive on autos and storage, calling Robotaxi plus Optimus the biggest long-term drivers with fleet forecasts of 1,500 by 2026 and 30,000 by 2030Source ↗
+15.40%07-02“Last issue's plan said 'cover before the print' — now we execute: a 7/27 earnings date pointed at 27% short interest is a room full of dry kindling, with B. Riley and Northland pouring accelerant from above ($66/$82 targets). This short earned its keep on the trend's collapse; don't get greedy on the last stretch of downhill — when a squeeze ignites, profits and principal burn in the same fire”
Score7/10Short interest ~27% of floatEarnings 7/27 after close1M -36.3%Contracted backlog ~$36B
Technicals — Tuesday's +7.9% close at $30.05 still sits 25% under the 50-day ($39.8) and 8% under the 200-day ($32.7) with RSI repairing at 40. The $32.7-33.3 zone (200-day/20-day) is where a covered short reassesses; support below at $28 and $24. With volatility rising into the event, the short's risk-reward has inverted
Fundamentals — Both sides hold hard evidence: bulls point to 1.4GW of contracted IT load, ~$36B in base rent and five campuses; bears counter with $2.7B of debt (~38% of market cap), GAAP losses widening to -$100.9M a quarter, 26x sales, and anchor tenant CoreWeave's own leverage cloud — the disagreement itself is the volatility
News — The 7/21 bounce came with no new lease and no new financing — purely analyst upgrades (B. Riley $53→$66, Northland $56→$82 with a 2026 top-pick tag) plus pre-earnings positioning. FY26 Q4 results land 7/27 after the close (consensus EPS -$0.24), inside the next brief's window; Polaris Forge 1's second building energized 75MW on 7/1
Short-term · This cycle
NeutralSidelines
Three reasons to cover: 7/27 event risk, squeeze fuel from 27% short interest, and a sentiment turn as the sell side raises in unison. The bear case (dilutive financing, tenant concentration) isn't disproven — the odds just no longer favor the short
Entry Short covered; reassess after the eventStop —Target —
Long-term · months+
Neutral
The contracted backlog means it won't die; the financing structure means it can't run far. Until dilution stops or the tenant base diversifies, trade the events, not a directional faith
The 7/27 print squeezing shorts on a beat — or reslicing the multiple on weak guidance
CoreWeave tenant concentration and its own credit
The financing-equals-dilution loop remains unbroken
Signal BacktestCumulative +15.40%price itself +16.52%1/1 closed trades wonprofitable since 07-07
07-02Short$35.52 → closed $30.0507-22+15.40%
Community Voices
StockTwits · Retail is still queued up catching knives across the neocloud four, and now the sell side has collectively turned to stand with them — when dip-buyers get institutional cover, shorts should start counting exitsOriginal ↗
Institutional Views
华尔街共识 · 14 analysts average $73.4, +144% upside, a perfect 1.0 all-Buy — every dollar this short made was snatched from consensus's mouth; take the win
Northland · $56 → $82, Outperform, named 2026 top pickSource ↗
B. Riley · $53 → $66, Buy, resting on ~$36B backlog and hyperscale long-term leasesSource ↗
0.00%07-18“Down 50% then up 37% inside a single week — that isn't price discovery, it's the dealer shuffling. Losing the 'world's best' crown to Kimi K3 halved the stock; buying a compiler team and a domestic-chip datacenter added 37% back. Under the table sits a 40% insider unlock in January 2027, and the institutions who paid HK$1,588 in the placement are still down over 20%. Watch the show by all means — but any chips you put on this table should be booked strictly as entertainment expense”
Score6/10Day +36.9%Prior 3 sessions Down nearly 50%Off post-IPO high -59%Next major unlock ~40% of shares, Jan 2027
Technicals — The +36.9% close at HK$1,219 is still 30% below the 20-day (HK$1,735), with no 200-day line to speak of (listed in January). A HK$322 ATR means 26% daily swings are 'normal range' — no stop-loss discipline survives that noise. Overhead, HK$1,479 (SMA50) and HK$1,588 (the placement price) form double trapped-supply resistance; below sits HK$890, the 7/20 low
Fundamentals — 2025 revenue of RMB 724M against a RMB 4.72B net loss, with price-to-sales once north of 1,300x at the peak; yet ARR has hit $1B ahead of the full-year target and GLM-5.2's token traffic jumped 27x in its first week on aggregator platforms — the demand is real, the valuation is faith. With the XCore Sigma acquisition and a 1GW domestic-chip buildout, the narrative is pivoting from pure models to models-plus-infrastructure
News — Three catalysts detonated the 7/21 rebound: closing the acquisition of XCore Sigma (the CAS Institute of Computing compiler team), announcing a 1GW all-domestic-chip AI datacenter partially in operation, and the disclosure that Hugging Face's security team deployed GLM-5.2 locally for attack forensics. The prior collapse chain: the 7/8 cornerstone unlock of 5.76%, the 7/13 HK$1,588 placement raising HK$31.4B, then Moonshot's 2.8-trillion-parameter Kimi K3 topping Code Arena over GLM-5.2 on 7/16 — sending the stock down a record 28.5% on 7/17
Short-term · 1-2 weeks
NeutralSidelines
No meaningful stop can be set on a name with a 26% daily ATR; price is driven entirely by news and float events (unlocks, placements, leaderboard turnover), rendering technical levels decorative. Trading resumes when volatility compresses and the float structure clears
Entry None — the volatility is untradeableStop —Target —
Long-term · months+
Neutral
The $1B ARR and domestic-compute sovereignty story are real substance, but foundation-model crowns change heads weekly; anyone holding long-term must first accept the valuation rebasing due before the January 2027 unlock
Supply shock from the ~40% insider unlock in January 2027
Rival model releases rewriting the scarcity premium at any moment
Commercialization pace against a RMB 4.7B annual loss
Community Voices
雪球/港股通 · Southbound flows flipped back to a net HK$7.17B buy on 7/21 — many of last week's stampeders and this week's knife-catchers are the same handsOriginal ↗
Institutional Views
华尔街共识 · 21 analysts average HK$1,663, +36% from here, at a 1.24 rating — though targets get rewritten weekly amid the violence, discount accordingly
摩根大通 · Overweight with the target marched up to HK$2,400 (from 1,800 on 6/22) — the bull standard-bearerSource ↗
高盛 · Neutral at HK$1,880: acknowledges scarcity value while flagging the ~40% insider unlock overhanging January 2027Source ↗
Led big-cap semis with +8.1% as the Microsoft AI partnership tailwind runs, but 6.9% off the high the chase math is mediocre — talk again at the 50-day
Playing neocloud kingmaker with the 9.3% Nebius stake while its own tape barely moved +2%; 65 analysts see +51% — wait for the dip, don't chase the plateau
Hong Kong's only breakout-screen name: 0.8% off the high after an +11.2% week as rerouting keeps freight rates bid — RSI 67 runs warm but the trend stands
Gold at $4,082 lit the miners: +10.1% on 2.2x volume, higher-torque than Zijin but purity cuts both ways in drawdowns — a leveraged expression of the gold long
Up 3.4% above both averages as the A-share V-reversal (STAR 50 +10.7%) lifts broker beta — the bull-market flagbearer, though the right side has only just begun
A +17% floor-to-ceiling rebound after the 7/16 Korea-probe crash of 23%, helped by TSMC mature-node price-hike chatter — volatility this high is for watching, not trading
A profit alert of +711-914% and Morgan Stanley's HK$230 Accumulate target against a price 53% off its high — the gap between alert and tape will close eventually; wait for right-side confirmation
A +5.8% bounce on the AI-server order narrative with SMCI's margin hike as sector tailwind, structurally sound 8.7% above the 50-day — but the best odds have passed
The federal fast-track for AI-datacenter nuclear is a real catalyst behind the +6.3% bounce — but pre-revenue with insider selling, and the 77%-off-high lesson is still warm
Short stopped out: an +18.8% squeeze day capping a +18.6% week — meme-stock short discipline means honoring the stop without argument; take the small loss, keep the principal
Closing at a stop: below both the 50- and 200-day with a -6.6% month — when a defensive name declines this offensively, step out first; the ledger settles here
After lithium's double hit (price plus impairments), an RSI-30 bounce of +3.6% — with the 9-analyst rating already split at 1.83, don't touch the left side
